NO20071299L - Vedvarende frigivelse farmasoytisk sammensetning av tolterodine - Google Patents
Vedvarende frigivelse farmasoytisk sammensetning av tolterodineInfo
- Publication number
- NO20071299L NO20071299L NO20071299A NO20071299A NO20071299L NO 20071299 L NO20071299 L NO 20071299L NO 20071299 A NO20071299 A NO 20071299A NO 20071299 A NO20071299 A NO 20071299A NO 20071299 L NO20071299 L NO 20071299L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- tolterodine
- sustained release
- release pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse angår en vedvarende frigivelse farmasøytisk sammensetning som innbefatter tolterodin, foretrukket tolterodintartrat, anvendelse av nevnte sammensetning for fremstilling av et medikament og en fremgangsmåte for fremstilling av en vedvarende frigivelse farmasøytisk sammensetning.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04020431A EP1629834A1 (en) | 2004-08-27 | 2004-08-27 | Sustained release pharmaceutical composition of tolterodine |
PCT/EP2005/009102 WO2006021425A1 (en) | 2004-08-27 | 2005-08-23 | Sustained release pharmaceutical composition of tolterodine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071299L true NO20071299L (no) | 2007-05-29 |
Family
ID=34926332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071299A NO20071299L (no) | 2004-08-27 | 2007-03-09 | Vedvarende frigivelse farmasoytisk sammensetning av tolterodine |
Country Status (7)
Country | Link |
---|---|
EP (3) | EP1629834A1 (no) |
AT (1) | ATE505187T1 (no) |
DE (1) | DE602005027469D1 (no) |
EA (1) | EA200700484A1 (no) |
NO (1) | NO20071299L (no) |
UA (1) | UA87515C2 (no) |
WO (1) | WO2006021425A1 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2645940A1 (en) * | 2006-03-21 | 2007-09-27 | Teva Pharmaceutical Industries Ltd. | Controlled release formulation of tolterodine |
EP1839649A1 (en) * | 2006-03-31 | 2007-10-03 | LEK Pharmaceuticals D.D. | Coated formulations for tolterodine |
KR100851033B1 (ko) * | 2007-02-12 | 2008-08-12 | 명문제약주식회사 | 엘-주석산 톨터로딘 함유 서방성 제제의 제조방법 |
US8871275B2 (en) | 2007-08-08 | 2014-10-28 | Inventia Healthcare Private Limited | Extended release compositions comprising tolterodine |
WO2011061616A2 (en) | 2009-11-23 | 2011-05-26 | Micro Labs Limited | Extended release compositions containing tolterodine and process for preparing the same |
WO2011095388A1 (en) | 2010-02-04 | 2011-08-11 | Synthon Bv | Tolterodine bead |
SG174658A1 (en) | 2010-04-01 | 2011-10-28 | Theravida Inc | Pharmaceutical formulations for the treatment of overactive bladder |
SG194809A1 (en) | 2011-05-10 | 2013-12-30 | Theravida Inc | Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder |
CN103211784B (zh) * | 2012-01-18 | 2017-07-11 | 北京天衡药物研究院有限公司 | 酒石酸托特罗定膜控缓释微丸胶囊 |
TW201422254A (zh) | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
JP6841834B2 (ja) | 2016-01-20 | 2021-03-10 | テラヴィダ, インコーポレイテッドTheraVida, Inc. | 多汗症の処置のための方法および組成物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE2061C1 (no) † | 1890-01-25 | |||
SE8800207D0 (sv) | 1988-01-22 | 1988-01-22 | Kabivitrum Ab | Nya aminer, deras anvendning och framstellning |
SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
US6274171B1 (en) † | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
WO1998003067A1 (en) | 1996-07-19 | 1998-01-29 | Gunnar Aberg | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
KR20000057548A (ko) | 1996-12-13 | 2000-09-25 | 알프레드 엘. 미첼슨 | 광학적 전송물질 및 결합재 |
SE9803871D0 (sv) † | 1998-11-11 | 1998-11-11 | Pharmacia & Upjohn Ab | Therapeutic method and formulation |
EP2153825A1 (en) * | 1998-08-27 | 2010-02-17 | Pfizer Health AB | Therapeutic formulation for administering tolterodine with controlled release |
DE19901692C2 (de) † | 1999-01-18 | 2002-06-20 | Gruenenthal Gmbh | Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes |
SI1227806T1 (sl) † | 1999-11-11 | 2005-12-31 | Pfizer Health Ab | Farmacevtska formulacija, ki vsebuje tolterodin in njena uporaba |
SE9904850D0 (sv) | 1999-12-30 | 1999-12-30 | Pharmacia & Upjohn Ab | Novel process and intermediates |
IN191835B (no) | 2001-08-03 | 2004-01-10 | Ranbaxy Lab Ltd | |
US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
US20030152624A1 (en) * | 2001-12-20 | 2003-08-14 | Aldrich Dale S. | Controlled release dosage form having improved drug release properties |
KR100540035B1 (ko) † | 2002-02-01 | 2005-12-29 | 주식회사 태평양 | 다단계 경구 약물 방출 제어 시스템 |
US7005449B2 (en) | 2002-04-23 | 2006-02-28 | Pharmacia & Upjohn Company | Tolterodine salts |
CN1150160C (zh) | 2002-04-29 | 2004-05-19 | 上海医药工业研究院 | L-酒石酸托特罗定的合成方法 |
WO2004105735A1 (en) | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Controlled release pharmaceutical compositions of tolterodine and processes for their preparation |
-
2004
- 2004-08-27 EP EP04020431A patent/EP1629834A1/en not_active Withdrawn
-
2005
- 2005-08-23 EA EA200700484A patent/EA200700484A1/ru unknown
- 2005-08-23 DE DE602005027469T patent/DE602005027469D1/de active Active
- 2005-08-23 EP EP08007539A patent/EP1964553A1/en not_active Withdrawn
- 2005-08-23 UA UAA200703260A patent/UA87515C2/ru unknown
- 2005-08-23 WO PCT/EP2005/009102 patent/WO2006021425A1/en active Application Filing
- 2005-08-23 AT AT05784596T patent/ATE505187T1/de not_active IP Right Cessation
- 2005-08-23 EP EP05784596.8A patent/EP1781275B2/en active Active
-
2007
- 2007-03-09 NO NO20071299A patent/NO20071299L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1964553A1 (en) | 2008-09-03 |
EP1629834A1 (en) | 2006-03-01 |
EP1781275A1 (en) | 2007-05-09 |
ATE505187T1 (de) | 2011-04-15 |
EP1781275B2 (en) | 2014-04-16 |
WO2006021425A1 (en) | 2006-03-02 |
UA87515C2 (ru) | 2009-07-27 |
EP1781275B1 (en) | 2011-04-13 |
EA200700484A1 (ru) | 2007-10-26 |
DE602005027469D1 (de) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20071299L (no) | Vedvarende frigivelse farmasoytisk sammensetning av tolterodine | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
NO20074086L (no) | Fremgangsmate for fremstilling av lansoprazol | |
NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
UY29112A1 (es) | Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica | |
CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
DK1881967T3 (da) | Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika | |
EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
NO20076687L (no) | Oral doseringsform | |
EA200700637A1 (ru) | Соли донепезила, подходящие для получения фармацевтических композиций | |
CY1113024T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου για τη θεραπεια της εξαρτησης ουσιων | |
ATE484494T1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
ATE453642T1 (de) | Substituierte phenylaminopyrimidine | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
SMT201200014B (it) | Nalmefene cloridrato diidrato. | |
ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
NO20080967L (no) | Benzimidazoler nyttige som inhibitorer av proteinkinaser | |
TW200612922A (en) | Inhibitors of hsp90 | |
WO2007025146A3 (en) | Balsalazide formulations and manufacture and use thereof | |
NO20075920L (no) | Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria | |
CY1108916T1 (el) | Υποκαθιστουμενες πυρρολες, οι ενωσεις που τις περιεχουν, διαδικασια παρασκευης και χρηση τους | |
CR7271A (es) | Formulaciones farmaceuticas novedosas a base de melatonina y compuestos similares para su uso en transtornos del sueno | |
ATE541573T1 (de) | Pharmazeutische zusammensetzung enthaltend lapatinib | |
WO2005082884A3 (en) | 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |